Archives for February 23, 2023

← 2023

Moderna seals pact with Life Edit Therapeutics to tackle genetic diseases with mRNA-based gene editing

23-Feb-2023

By Jonathan Smith

The messenger RNA (mRNA) specialist Moderna has teamed up with ElevateBio-owned Life Edit Therapeutics to develop gene editing therapies that are delivered into patients in vivo.

Cell therapy for sickle cell disease abandoned as Graphite Bio lays off 50% of workforce

23-Feb-2023

By Jonathan Smith

After voluntarily pausing a phase 1/2 trial due to safety concerns in January 2023, the gene edited cell therapy firm Graphite Bio has discontinued the development of nulabeglogene autogedtemcel (nula-cel), its lead candidate cell therapy for sickle cell...